Page 1203 - Small Animal Internal Medicine, 6th Edition
P. 1203

CHAPTER 67   Disorders of Muscle   1175





  VetBooks.ir























                  A




                                                                 FIG 67.2
                                                                 Bilateral exophthalmos and upper eyelid retraction caused
                                                                 by extraocular myositis in a Border Collie.



                                                                 in acutely affected dogs and a more gradual improved ability
                                                                 to open the mouth in chronically affected dogs. After about
                                                                 3  weeks,  the  dose  of  corticosteroids  can  be  decreased  (to
                                                                 1 mg/kg q24h) and then gradually tapered over 4 to 6 months
                                                                 to the lowest possible alternate-day dose. Inadequate dosing
             B                                                   or treatment for an insufficient period of time is associated
                                                                 with a high rate of relapse. Dogs that do not respond ade-
            FIG 67.1                                             quately to corticosteroid therapy and dogs that relapse each
            Chronic masticatory muscle myositis (MMM) causing (A)   time attempts are made to decrease the dose may benefit
            severe temporalis and masseter muscle atrophy and (B)
            inability to open the mouth more than a few centimeters in   from use of other immunosuppressive drugs, such as aza-
            an adult Vizsla.                                     thioprine (Imuran [Burroughs Wellcome] given 2 mg/kg PO
                                                                 once daily until the patient shows signs of improvement,
                                                                 then every 48 hours) or cyclosporine (Atopica, 6 mg/kg PO
            aminotransferase (AST), and globulin concentrations are   q12h). Dogs treated aggressively have a good prognosis for
            occasionally increased. Proteinuria sometimes occurs. Cir-  recovery. They should be carefully monitored for relapse
            culating antibodies against masticatory myosin binding   (using jaw mobility and discomfort, and serum CK), particu-
            protein-C can be detected in the serum of many (80%-90%)   larly as the glucocorticoid dose is tapered. Lifelong treatment
            dogs with acute MMM, but they may not be present in   may be required.
            dogs with chronic disease. Electromyography (EMG), when   Historically it was recommended that dogs with chronic
            available, can demonstrate acute myositis in the masticatory   MMM have their jaws opened by force under anesthesia to
            muscles  and  confirm  that  other  muscle  groups are  unaf-  stretch  the fibrous tissue  and muscle. This practice  is not
            fected, making PM less likely. Histopathologic evaluation of   recommended because it does not improve clinical outcome,
            a biopsy from the affected muscles establishes the diagno-  it increases the inflammation in torn muscle fibers, and it
            sis. Fresh and formalin-fixed muscle should be submitted to   carries an inherent risk of iatrogenic mandibular luxation or
            permit the use of histochemical and immunohistochemical   fracture.
            stains to identify antibody bound to type 2M muscle fibers.
                                                                 EXTRAOCULAR MYOSITIS
            Treatment                                            A unique form of myositis confined to the extraocular
            Oral (PO) administration of glucocorticoids (prednisone,   muscles, resulting in acute exophthalmos, has been described
            1-2 mg/kg q12h) usually results in rapid elimination of pain   in dogs (Fig. 67.2). Affected dogs are usually young, with a
   1198   1199   1200   1201   1202   1203   1204   1205   1206   1207   1208